GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sanofi Consumer Healthcare India Ltd

Sanofi Consumer Healthcare: Q3 FY27 Profit ₹766 Million, Revenue ₹2,631 Million

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 28 Oct 2026, 06:21 PM IST  ·  BSE ID: e6dc0ab5-d90e-41fb-b105-b8f1bdf3d37f
View Original BSE Filing (PDF)
💡
In Simple Terms
The company announced its latest financial results, reporting a profit of ₹766 Million and revenue of ₹2,631 Million for the quarter.
🤖 AI Summary
  • Sanofi Consumer Healthcare India Ltd's Board approved unaudited financial results for Q3 FY27 on October 28, 2026.
  • Profit for the quarter ended September 30, 2026, was ₹766 Million.
  • Revenue from Operations for the quarter ended September 30, 2026, reached ₹2,631 Million.
  • Basic and diluted earnings per share for the quarter were ₹33.26.
  • The results were accompanied by a Limited Review Report from statutory auditors.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q3 FY27)
₹2,631 Million
12.48%
Profit for the period (Q3 FY27)
₹766 Million
21.78%
EPS (Basic and Diluted) (Q3 FY27)
₹33.26
21.78%
Revenue from Operations (Nine Months FY27)
₹7,280 Million
16.04%
Profit for the period (Nine Months FY27)
₹2,132 Million
22.81%
🏢 How This Affects the Company
📈
Business Impact
Revenue from Operations for the quarter ended September 30, 2026, increased by 12% year-on-year, indicating continued sales growth in its 'Pharmaceutical Business' segment.
💰
Financial Impact
Profit for the period rose to ₹766 Million, up from ₹629 Million in the prior comparable quarter, contributing to a nine-month profit of ₹2,132 Million.
👥 What This Means For Shareholders
✅
Action Required
No specific action is required from shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected as these results reflect the company's financial performance and profitability for the quarter and nine months ended September 30, 2026, impacting future valuations.
🔍
Management Signal
The approval of unaudited financial results and their public disclosure signal management's adherence to regulatory compliance and commitment to transparent reporting.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Q4 FY27 results — monitor annual revenue and profit trends.
Any further updates on new product launches or distribution expansion initiatives.
Regulatory filings detailing any changes in the company's segment reporting or corporate structure.
LOW RISK The filing reports routine financial results with no new risks identified.
💡 Investor Takeaway
Sanofi Consumer Healthcare India Ltd reported Profit for the period of ₹766 Million for the quarter ended September 30, 2026, a 21.78% increase from ₹629 Million in Q3 FY26. Revenue from Operations grew 12.48% to ₹2,631 Million from ₹2,339 Million.
⚖️ Strengths & Concerns

✅ Positives

  • Profit for the quarter ended September 30, 2026, increased to ₹766 Million from ₹629 Million in the prior comparable quarter.
  • Revenue from Operations for the quarter ended September 30, 2026, grew to ₹2,631 Million from ₹2,339 Million in the prior comparable quarter.

⚠️ Concerns

  • Purchases of stock in trade for the nine months ended September 30, 2026, decreased to ₹457 Million from ₹641 Million in the prior comparable period.
  • Changes in Inventories of stock in trade and finished goods for the nine months ended September 30, 2026, showed a positive change of ₹28 Million compared to a negative change of (₹131) Million in the prior comparable period.
📅 Company Track Record
Sanofi Consumer Healthcare India Limited was demereged from Sanofi India Limited on June 1, 2024. Past Q3 FY27 profit rose 21.78% to ₹766 Million on 12.48% higher revenue of ₹2,631 Million. Q1 FY27 profit was ₹688 Million on revenue of ₹2,357 Million.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Sanofi Consumer Healthcare India Ltd's profit for the quarter ended September 30, 2026?
Sanofi Consumer Healthcare India Ltd reported a Profit for the period of ₹766 Million for the quarter ended September 30, 2026.
What was Sanofi Consumer Healthcare India Ltd's revenue from operations for Q3 FY27?
Revenue from Operations for Sanofi Consumer Healthcare India Ltd for the quarter ended September 30, 2026, was ₹2,631 Million.
What was the Basic and Diluted Earnings Per Share for Sanofi Consumer Healthcare India Ltd in Q3 FY27?
The Basic and Diluted Earnings Per Share for Sanofi Consumer Healthcare India Ltd for the quarter ended September 30, 2026, was ₹33.26.
How did Sanofi Consumer Healthcare India Ltd's nine-month profit compare year-on-year?
Profit for the nine months ended September 30, 2026, was ₹2,132 Million, compared to ₹1,736 Million for the nine months ended September 30, 2025.
What was Sanofi Consumer Healthcare India Ltd's revenue from operations for the nine months ended September 30, 2026?
Revenue from Operations for the nine months ended September 30, 2026, was ₹7,280 Million.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.